Lotus Pharmaceutical Co Ltd Capital Reinvestment Ratio
Lotus Pharmaceutical Co Ltd capital reinvestment ratio. Lotus Pharmaceutical Co Ltd (1795) has a Capital Reinvestment Ratio of 0.14x as of June 2026, meaning it reinvests 0% of its operating cash flow (NT$701.37 Million) in capital expenditures (NT$97.92 Million). See how much free cash does Lotus Pharmaceutical Co Ltd generate to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Lotus Pharmaceutical Co Ltd (2009–2025)
Capital reinvestment ratio of Lotus Pharmaceutical Co Ltd from 2009 to 2025. This chart tracks Lotus Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 13 annual periods. See Lotus Pharmaceutical Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Lotus Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2009–2025)
Lotus Pharmaceutical Co Ltd capital reinvestment ratio by year from 2009 to 2025. For the full cash flow conversion analysis, see Lotus Pharmaceutical Co Ltd (1795) cash conversion ratio.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.58x | NT$7.48 Billion | NT$4.35 Billion | ▲ +144.4% |
| 2024 | 0.24x | NT$6.15 Billion | NT$1.47 Billion | ▼ -88.3% |
| 2023 | 2.03x | NT$1.61 Billion | NT$3.28 Billion | ▲ +1207.5% |
| 2022 | 0.16x | NT$3.72 Billion | NT$577.16 Million | ▼ -98.9% |
| 2021 | 13.50x | NT$119.66 Million | NT$1.62 Billion | ▲ +1217.2% |
| 2020 | 1.03x | NT$1.95 Billion | NT$2.00 Billion | ▼ -71.9% |
| 2019 | 3.64x | NT$302.81 Million | NT$1.10 Billion | ▲ +627.3% |
| 2018 | 0.50x | NT$796.98 Million | NT$399.07 Million | ▼ -67.6% |
| 2017 | 1.54x | NT$592.29 Million | NT$914.84 Million | ▲ +188.3% |
| 2016 | 0.54x | NT$1.23 Billion | NT$660.48 Million | ▲ +10.9% |
| 2015 | 0.48x | NT$1.08 Billion | NT$520.71 Million | ▼ -80.6% |
| 2010 | 2.49x | NT$59.19 Million | NT$147.57 Million | ▲ +786.5% |
| 2009 | 0.28x | NT$89.50 Million | NT$25.17 Million | — |